4
Changes in Ownership
Edgewise Therapeutics, Inc. Filed Acc 0001644087-26-000002
CMO sold 21,338 shares at $32.12 ($685,308)
- CMO acquired 21,338 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Donovan Joanne M. · CMO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-31 | Exercise or conversion : show line 1 in the form 10b5-1 | +21,338 | $7.08 | $151,073 | 30,935 | D |
| 2026-03-31 | Sale : show line 2 in the form 10b5-1 | −21,338 | $32.12 | $685,308 | 9,597 | D |
| Open-market sales · 21,338 sh · avg $32.12 · $685,308 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-31 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −21,338 | 153,662 | D |
Loading xslF345X06/primarydocument.xml…